Impact of β-blocker therapy on functional capacity criteria for heart transplant listing

Journal of Heart and Lung Transplantation

Volumn 22, Issue 1, 2003, Pages 78-86

  Pohwani, Amar L ^a   Murali, Srinivas ^a   Mathier, Michael M ^a   Tokarczyk, Tammy ^a   Kormos, Robert L ^a   McNamara, Dennis M ^a   MacGowan, Guy A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; METOPROLOL;

ADULT; AGED; ARTICLE; ASSISTED CIRCULATION; CONTROLLED STUDY; DEATH; DRUG USE; EVALUATION; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART FUNCTION; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; CASE-CONTROL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 0037229373     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00480-1     Document Type: Article

References (18)

1. 2. A simple yet enduring standard. Circulation. 101:2000;1080-1082.
2. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds L.H., Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 83:1991;778. 776.
3. Stelken A.M., Younis L.T., Jennison S.H., et al. Prognostic value of cardiopulmonary exercise testing using percent achieved peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol. 27:1996;345-352.
4. MacGowan G.A., Janosko K., Cecchetti A., Murali S. Exercise-related ventilatory abnormalities and survival in congestive heart failure. Am J Cardiol. 79:1997;1264-1266.
5. Chua T.P., Ponikowski P., Harrington D., et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol. 29:1997;1585-1590.
6. Aaronson K., Schwartz J.S., Chen T., Mancini D. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplantation. Circulation. 95:1997;2660-2667.
7. Deng M.C., De Meester J.M.J., Smits J.M.A., Heinecke J., Scheld H.H. Effect of receiving a heart transplant analysis of a national cohort entered on to a waiting list, stratified by heart failure severity . BMJ. 321:2000;540-545.
8. Packer M., Coats A.J.S., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658.
9. Metra M., Giubbini R., Nodari S., Boldi E., Modena M.G., Cas L.D. Differential effects of β-blockers in patients with heart failure A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol . Circulation. 102:2000;546-551.
10. Gilbert E.M., Abraham W.T., Olsen S., et al. Comparative hemodynamic, left ventricular functional and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation. 94:1996;2817-2825.
11. Wasserman K., Beaver W.L., Whipp B.J. Gas exchange theory and the lactic acidosis (anaerobic) threshold. Circulation. 81:(suppl 2):1990;14.
12. Wasserman K., Hansen J.E., Sue D.Y., Whipp B.J. Principles of exercise testing and interpretation. 1986;Lea and Febiger, Philadelphia. p. 73.
13. Packer M., Bristow M.R., Cohn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
14. Effect of metoprolol CR/XL in chronic heart failure metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF) . Lancet. 353:1999;2001-2007.
15. http.//www.patients.unos.org/tpd/frm_stats, March 1, 2002.
16. McNamara D.M., Holubkov R., Janosko K., et al. Pharmacogenetic interactions between β-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation. 103:2001;1644-1648.
17. MacGowan G.A., Panzak G., Murali S. Exercise-related ventilatory abnormalities are more specific for functional impairment in chronic heart failure than reduction in peak exercise oxygen consumption. J Heart Lung Transplant. 20:2001;1167-1173.
18. Wikstrand JC, Hjalmarson A, Waagstein F, et al. Achieved metoprolol CR/XL dose and clinical outcomes. Analysis of the experience with MERIT-HF (abstract). Circulation 2001; 104:II-753.